Blood-based genomic profiling of circulating tumor DNA from patients with advanced biliary tract cancer.

被引：0
|
作者：
Wang, Junying
Song, Jia
Zhao, Jing
Zhang, Yuzi
Cai, Shangli
Chen, Chen
机构：
[1] Southeast Univ, Zhongda Hosp, Nanjing, Jiangsu, Peoples R China
[2] 3D Med Inc, Med Dept, Shanghai, Peoples R China
[3] Hunan Normal Univ, Affiliate Hosp 1, Hunan Prov Peoples Hosp, Changsha, Hunan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.1576
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1576
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Circulating Tumor DNA Profiling of Advanced Biliary Tract Cancers (Mar, 10.1200/PO.18.00324, 2019)
    Mody, K.
    Kasi, P. M.
    Yang, J. D.
    Surapaneni, P. K.
    JCO PRECISION ONCOLOGY, 2021, 5 : 1860 - 1860
  • [32] Clinical significance of circulating tumor cells in blood from patients with advanced or recurrent esophageal cancer.
    Tanaka, Motomu
    Takeuchi, Hiroya
    Hiraiwa, Kunihiko
    Nakamura, Rieko
    Takahashi, Tsunehiro
    Wada, Norihito
    Kawakubo, Hirofumi
    Saikawa, Yoshiro
    Omori, Tai
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [33] Genomic profiling of circulating tumor DNA (ctDNA) from patients (pts) with metastatic breast cancer (mBC).
    Pusztai, Lajos
    Chung, Jon
    Young, Lauren
    Schrock, Alexa Betzig
    Hartmaier, Ryan
    Frampton, Garrett Michael
    Gay, Laurie M.
    Stephens, Phil
    Miller, Vincent A.
    Ali, Siraj Mahamed
    Ross, Jeffrey S.
    Vahdat, Linda T.
    O'Shaughnessy, Joyce
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [34] Genomic profiling of circulating tumor DNA (ctDNA) from patients (pts) with advanced non-small cell lung cancer (NSCLC).
    Dagogo-Jack, Ibiayi
    Bernicker, Eric
    Li, Tianhong
    Wang, Victoria
    Ross, Jeffrey S.
    Young, Lauren
    Stephens, Philip J.
    Chung, Jon
    Shaw, Alice Tsang
    Ali, Siraj Mahamed
    Miller, Vincent A.
    Schrock, Alexa Betzig
    Spigel, David R.
    Ou, Sai-Hong Ignatius
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [35] DNA methylation profiling from circulating tumor DNA for early-detection of colorectal cancer.
    Zhang, Wei
    Sui, Jinke
    Wu, Xianrui
    Cao, Fuao
    Yu, Guanyu
    Wang, Chenyang
    Zhang, Zhihong
    Li, Bingsi
    Fang, Shuai
    Han Han-Zhang
    Lou, Zheng
    Gong, Haifeng
    Liu, Lianjie
    Zheng, Nanxin
    Hao, Liqiang
    Lan, Ping
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [36] Circulating tumor DNA-based mutational landscape of advanced colorectal cancer.
    Yan, Fang
    Gao, Wei
    Zhu, Lifei
    Xie, Wenzhuan
    Gao, Chan
    Zhao, Jing
    Huang, Mengli
    Cai, Shangli
    Zhong, Yi
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] A comparative study of blood-based KRAS mutation analysis in circulating tumor cells versus circulating plasma DNA to predict primary tumor mutations in lung cancer.
    Lim, Eric Kian Saik
    Freidin, Maxim B.
    Freydina, Dasha V.
    Chudasama, Dimple
    Leung, Maria
    Popat, Sanjay
    de Castro, David Gonzalez
    Rice, Alexandra
    Anikin, Vladimir
    Fernandez, Angeles Montero
    Nicholson, Andrew G.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [38] Blood-based circulating tumor DNA mutations as a diagnostic and prognostic biomarker for lung cancer
    Leung, Maria
    Freidin, Maxim B.
    Freydina, Dania, V
    Von Crease, Charlotte
    De Sousa, Paulo
    Barbosa, Monica T.
    Nicholson, Andrew G.
    Lim, Eric
    CANCER, 2020, 126 (08) : 1804 - 1809
  • [39] A novel combination of tissue-informed, comprehensive genomic profiling (CGP) and non-bespoke blood-based profiling for quantifying circulating tumor DNA (ctDNA)
    Driessen, Terri
    Lo, Christine
    Zhu, Wei
    Tell, Robert
    Freaney, Jonathan
    Nimeiri, Halla
    Sasser, Kate
    CANCER RESEARCH, 2024, 84 (06)
  • [40] Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics
    Choi, In Sil
    Kato, Shumei
    Fanta, Paul T.
    Leichman, Lawrence
    Okamura, Ryosuke
    Raymond, Victoria M.
    Lanman, Richard B.
    Lippman, Scott M.
    Kurzrock, Razelle
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (10) : 1852 - 1862
12345